Heparin sodium – APP Pharmaceuticals
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Heparin sodium – APP Pharmaceuticals, covering 2012-08-13 to 2012-08-13. Get the full timeline:
Most recent: Clinical Trial Update: PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS [Phase 1]